These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 594965)
21. Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides. du Vivier A; Vollum DI Br J Dermatol; 1980 Mar; 102(3):319-22. PubMed ID: 7370179 [TBL] [Abstract][Full Text] [Related]
22. Skin directed therapy for mycosis fungoides: a review. Berthelot C; Rivera A; Duvic M J Drugs Dermatol; 2008 Jul; 7(7):655-66. PubMed ID: 18664158 [TBL] [Abstract][Full Text] [Related]
23. Topical mechlorethamine therapy for mycosis fungoides. Proposed schedule to overcome drug resistance. Volden G; Molin L; Thomsen K Arch Dermatol; 1982 Feb; 118(2):138-9. PubMed ID: 7059219 [No Abstract] [Full Text] [Related]
24. Photochemotherapy for mycosis fungoides: a clinical and histological study. Lowe NJ; Cripps DJ; Dufton PA; Vickers CF Arch Dermatol; 1979 Jan; 115(1):50-3. PubMed ID: 760657 [TBL] [Abstract][Full Text] [Related]
25. [Change of level of mycosis fungoides under systemic PUVA-therapy (author's transl)]. Tourbier H; Schultz-Ehrenburg U Z Hautkr; 1981 Jul; 56(14):923-9. PubMed ID: 7269717 [TBL] [Abstract][Full Text] [Related]
26. Mycosis fungoides treated by PUVA and mustine hydrochloride. du Vivier A; Vollum D Br Med J; 1978 Nov; 2(6147):1300-1. PubMed ID: 709338 [No Abstract] [Full Text] [Related]
28. Failure of periodic ultraviolet radiation treatments to prevent sensitization to nitrogen mustard: a case report. Vega FA; Halprin KM; Taylor JR; Woodyard C; Comerford M Br J Dermatol; 1982 Mar; 106(3):361-6. PubMed ID: 7066193 [TBL] [Abstract][Full Text] [Related]
29. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not? Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030 [TBL] [Abstract][Full Text] [Related]
35. Retinoid dermatitis mimicking progression in mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Group. Molin L; Thomsen K; Volden G; Lange Wantzin G Acta Derm Venereol; 1985; 65(1):69-71. PubMed ID: 2578710 [TBL] [Abstract][Full Text] [Related]
36. Treatment of mycosis fungoides with psoralen and long-wave ultraviolet light-A (PUVA). Nozicková M; Simková M; Nozicka Z Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1987; 30(1):179-94. PubMed ID: 3481871 [No Abstract] [Full Text] [Related]
37. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group. Molin L; Thomsen K; Volden G; Groth O Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215 [TBL] [Abstract][Full Text] [Related]
38. Transfer factor therapy in mycosis fungoides: a double-blind study. Thestrup-Pedersen K; Grunnet E; Zachariae H Acta Derm Venereol; 1982; 62(1):47-53. PubMed ID: 6175137 [TBL] [Abstract][Full Text] [Related]
39. The treatment of mycosis fungoides: adjuvant topical mechlorethamine after electron beam therapy. Price NM; Hoppe RT; Constantine VS; Fuks ZY; Farber EM Cancer; 1977 Dec; 40(6):2851-3. PubMed ID: 412580 [TBL] [Abstract][Full Text] [Related]
40. Normalized light reactions in mycosis fungoides patients after complete remission of skin lesions. Volden G Acta Derm Venereol; 1980; 60(2):161-63. PubMed ID: 6155026 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]